Navigation Links
If Herceptin is Approved in Combination With Other Emerging Therapies it Will be in a Position to Retain Patient Share From Tykerb/Tyverb for the Treatment of HER2-Positive Breast Cancer
Date:2/11/2009

tool that provides in-depth analysis of unmet need, physician expectations of new therapies and commercial dynamics to help pharmaceutical companies optimize their investments in drug development.

The report can be purchased by contacting Decision Resources. Members of the media may request an interview with an analyst.

About Decision Resources

Decision Resources (www.decisionresources.com) is a world leader in market research publications, advisory services and consulting designed to help clients shape strategy, allocate resources and master their chosen markets. Decision Resources is a Decision Resources, Inc. company.

About Decision Resources, Inc.

Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources, Inc. at www.DecisionResourcesInc.com.

All company, brand or product names contained in this document may be trademarks or registered trademarks of their respective holders.

    For more information, contact:
    Natalia Morales                              Elizabeth Marshall
    Decision Resources                           Decision Resources, Inc.
    781-296-2691                                 781-296-2563
    nmorales@dresources.com                      emarshall@dresources.com


'/>"/>
SOURCE Decision Resources
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Xeloda(R), Taxotere(R) and Herceptin(R) Combination Study Suggests Clinical Benefit in Invasive Breast Cancer with Shortened Treatment Cycle
2. Herceptin helps women with multiple chromosomes containing HER2 gene, study finds
3. Shengtai Pharmaceutical, Inc. Comments on Chinas Recently Approved Health Care Reform Plan
4. Federal Trade Commission Files Complaint Against Par Pharmaceutical Over Court-Approved AndroGel(R) Litigation Settlement
5. A Newly Approved CMS Medicare Package Expands Reimbursement Coverage for Telehealth Originating Sites Beginning January 1, 2009
6. CSL Behring Receives FDA Approval of RiaSTAP(TM), First and Only Approved Treatment of Acute Bleeding Episodes in Patients with Congenital Fibrinogen Deficiency
7. Alliance for Pediatric Quality Supports New ANSI-Approved Standard for Child Health Passed by HL7
8. New Roche Dual Target HIV-1 Test Approved for Use in European Union
9. The First Treatment Specifically Approved for Huntingtons Disease Patients is Now Available in the United States
10. Bayer Marketing Two Unapproved Aspirin Products: FDA
11. Upscale New York City Skin Care Center Juva Offering FDA Approved Fraxel re:fine System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... TX (PRWEB) August 21, 2014 Improv ... 20 entertained residents with dementia at Silverado Turtle Creek ... Troupe, which consists of entertainers ranging from ages 10 ... time they perform their 40-minute set. The troupe's philosophy ... it universal and allows them to touch audiences regardless ...
(Date:8/21/2014)... THURSDAY, Aug. 21, 2014 (HealthDay News) -- Black mothers ... babies, and here,s one possible reason why: Hospitals in ... nursing than those in areas with more white residents, ... support breast-feeding are much less common in medical centers ... from the U.S. Centers for Disease Control and Prevention ...
(Date:8/21/2014)... Honolulu (PRWEB) August 21, 2014 ... its 10th anniversary and a national voice in ... leaders in health disparities during the 112th National ... , Distinguished honorees included: , John Ruffin, Ph.D, ... Health and Health Disparities, whose life-long career and ...
(Date:8/21/2014)... rural communities do not routinely screen women for ... medical and public health researchers. Rural women who ... if they seek help., "Rural health care providers ... S. McCall-Hosenfeld, a primary care physician and assistant ... State College of Medicine. "However, in rural settings, ...
(Date:8/21/2014)... 2014 The report "Industrial Flue ... Control System (FGD, DeNOx, Particulate Control, Mercury Control) ... Chemical & Others) - Global Trends & Forecasts ... flue gas treatment systems & services market with ... in terms of value. The industrial flue gas ...
Breaking Medicine News(10 mins):Health News:Unicorn Clearance Improv Troupe Brings Laughter to Residents with Dementia at Silverado Memory Care 2Health News:Racial Disparities in Breast-Feeding May Start With Hospitals, Study Suggests 2Health News:W. Montague Cobb/NMA Health Institute Honors Three Outstanding Leaders in Health Disparities 2Health News:Primary care physicians can be critical resource for abused women in rural areas 2Health News:Industrial Flue Gas Treatment Systems Market Estimated to Worth $59, 546.7 Million by 2019 – Report by MarketsandMarkets 2Health News:Industrial Flue Gas Treatment Systems Market Estimated to Worth $59, 546.7 Million by 2019 – Report by MarketsandMarkets 3Health News:Industrial Flue Gas Treatment Systems Market Estimated to Worth $59, 546.7 Million by 2019 – Report by MarketsandMarkets 4
... a condition of the skin that affects more than 80 ... While stress has often been cited // as a source ... ,Twenty-two university students participated in this study. Each participant had ... study. Exam sessions are common sources of stress for students. ...
... report more than half a million women in developing countries ... Safe Motherhood and Newborn Health //are intensifying support to countries ... die while giving birth to her child. ,The ... skilled birth attendants who can help a woman give birth ...
... integrate cardiovascular activity into their lives, such as walking, would ... the study researchers surveyed nearly 18,800 women, ages 70 to ... The data show women who walked for at least 1.5 ... than those who walked less than 40 minutes per week. ...
... reduces the risk of recurrence in women with stage I ... ovary). ,About one quarter of all ovarian cancers are ... 85 percent. Most doctors may prefer not to offer chemotherapy ... treated by surgery alone , thus doctors say that giving ...
... room may be the healthiest environment for your child at ... // may put children at risk for leukemia. Researchers ... the circadian rhythm and suppress the production of melatonin. ... to protect DNA from oxidative damage. Once damaged, DNA may ...
... best friend might be able to detect bladder cancer . ... from malignant tumors in urine samples. ,Six dogs ... to discriminate between urine from patients with bladder cancer and ... samples of urine from six control group participants and one ...
Cached Medicine News:Health News:WHO acts to reduce the maternal death toll 2
(Date:8/21/2014)... Aug. 21, 2014 CVS Caremark Corporation (NYSE: ... Reference Yields and consideration payable in connection with its previously ... 7, 2014 for (1) any and all of its 6.250% ... (2) up to a maximum amount of its 6.125% Senior ... Senior Notes due 2017 (collectively, the "Maximum Tender Offer Notes" ...
(Date:8/21/2014)... 21, 2014  Cyberonics, Inc. (NASDAQ: CYBX ) ... Quarterly highlights 1   Operating ... the first quarter of fiscal 2014, and other achievements, include: ... increase of 6.8%; , Strong international net sales of ... basis; , U.S. net product sales reached a new ...
(Date:8/20/2014)...  The National Association of Drug Diversion Investigators ... the real-time, pseudoephedrine (PSE) blocking system in Indiana. The ... (NPLEx), automatically blocks unlawful PSE sales and helps ... make arrests. Data released by NPLEx shows electronic ... the sale of more than 32,105 boxes of medicine ...
Breaking Medicine Technology:CVS Caremark Corporation Announces Early Results of Tender Offers, Pricing, Election of Early Settlement and Increase in the Maximum Tender Offer Amount 2CVS Caremark Corporation Announces Early Results of Tender Offers, Pricing, Election of Early Settlement and Increase in the Maximum Tender Offer Amount 3CVS Caremark Corporation Announces Early Results of Tender Offers, Pricing, Election of Early Settlement and Increase in the Maximum Tender Offer Amount 4CVS Caremark Corporation Announces Early Results of Tender Offers, Pricing, Election of Early Settlement and Increase in the Maximum Tender Offer Amount 5CVS Caremark Corporation Announces Early Results of Tender Offers, Pricing, Election of Early Settlement and Increase in the Maximum Tender Offer Amount 6Cyberonics Reports Fiscal 2015 First Quarter Results 2Cyberonics Reports Fiscal 2015 First Quarter Results 3Cyberonics Reports Fiscal 2015 First Quarter Results 4Cyberonics Reports Fiscal 2015 First Quarter Results 5Cyberonics Reports Fiscal 2015 First Quarter Results 6Cyberonics Reports Fiscal 2015 First Quarter Results 7Cyberonics Reports Fiscal 2015 First Quarter Results 8Cyberonics Reports Fiscal 2015 First Quarter Results 9Cyberonics Reports Fiscal 2015 First Quarter Results 10Cyberonics Reports Fiscal 2015 First Quarter Results 11Cyberonics Reports Fiscal 2015 First Quarter Results 12Cyberonics Reports Fiscal 2015 First Quarter Results 13Cyberonics Reports Fiscal 2015 First Quarter Results 14Cyberonics Reports Fiscal 2015 First Quarter Results 15Cyberonics Reports Fiscal 2015 First Quarter Results 16Indiana's Stop-Sale System Achieves Significant Results In Battle Against Meth 2
... 7, 2012  Provectus Pharmaceuticals, Inc. (OTCBB: PVCT, ... dermatology biopharmaceutical company, today announced that its ... for on-demand viewing. LINK:  ... now" button Provectus Pharmaceuticals, Inc,s ...
... May 7, 2012 A new analysis concludes that rituximab, ... treatment responses lasting at least five years in approximately one ... of bleeding due to chronic immune thrombocytopenic purpura (ITP). In ... Blood , the Journal of the American Society ...
Cached Medicine Technology:Provectus Pharmaceuticals, Inc.'s Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com 2Rituximab Promotes Long-Term Response for Patients with Immune Destruction of Platelets 2Rituximab Promotes Long-Term Response for Patients with Immune Destruction of Platelets 3
... 800 Series KTP/YAG Surgical Laser System ... It is a high-power, dual-wavelength system ... surgery, orthopedics, general surgery, neurosurgery, pulmonary ... beam surgically cuts, vaporizes and coagulates ...
... of 532 nm lasers are distinguished from ... solid-state design. A compact and sealed ... and reliable for a broad range of ... hemoglobin and an adjustable pulse length, the ...
... Ceralas D15/810 diode laser is a versatile ... many soft tissue applications. With excellent hemostatic ... a flexible fiber optic delivery system that ... dry environments alike.,Compact and portable, the Ceralas ...
... monoclonal antibody based colorimetric test intended ... gonorrhoeae. The test requires less than ... heating or pretreatment. The test does ... cultures. GonoGen&trade II eliminates agglutination, guesswork, ...
Medicine Products: